Company: BLNE
Filing Date: 2025-01-14
Form Type: 424B3
Source: 0001493152-25-002137
Chunk: 107

Company: Beeline Holdings, Inc.
Filing Date: 2025-01-14
Form: 424B3
Chunk 107
---
 of the Shares pursuant to the Registration Rights Agreement, including, without limitation, SEC filing fees and expenses of compliance with state securities or “blue sky” laws; provided, however, a Selling Stockholder will pay all underwriting discounts and selling commissions, if any. We will indemnify the Selling Stockholders against liabilities, including some liabilities under the Securities Act in accordance with the Registration Rights Agreements or the Selling Stockholders will be entitled to contribution. We may be indemnified by the Selling Stockholders against civil liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the Selling Stockholder specifically for use in this Prospectus, in accordance with the related registration rights agreements or we may be entitled to contribution.

Once sold under the Registration Statement, of which this Prospectus forms a part, the Shares will be freely tradable in the hands of persons other than our affiliates.

<div align='center'>MARKET FOR REGISTRANT’S COMMON EQUITY AND

RELATED STOCKHOLDER MATTERS</div>

Our Common Stock issued is quoted on Nasdaq under the symbol “EAST.” On December 10, 2024, the last reported sale price of our Common Stock on Nasdaq was $0.84 per share.

As of December 10, 2024, there were an estimated 87 holders of record of our Common Stock. As of that date, a total of 3,090,750 shares of our Common Stock were held in street name by additional beneficial owners.

<div align='center'>DESCRIPTION OF SECURITIES</div>

Our authorized capital stock consists of 6,000,000 shares of Common Stock, par value $0.0001 per share, of which 4,689,503 shares are outstanding as of December 31, 2024, and 100,000,000 shares of “blank check” preferred stock, par value $0.0001 per share, 2,500,000 shares of Series B are authorized and outstanding, 255,474 shares of Series D are authorized, of which 255,474 shares are outstanding, 200,000 shares of Series E are authorized, of which shares 200,000 are outstanding, 70,000,000 shares of Series F are authorized, of which 69,085,562 shares are outstanding, 1,000,000 shares of Series F-1 are authorized, of which 517,775 shares are outstanding, and 6,000,000 shares of Series G are